VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies

NCT00070538 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: cytarabine
DRUG: laromustine

Sponsor

Vion Pharmaceuticals

Collaborators

[object Object]